维普期刊资源整合服务平台（V6.5）

501篇 您的检索式：作者名="Moore RG"

选中清除导出查看参考文献查看引证文献引用追踪共26页首页上一页第1页下一页末页 /26 跳转

	题名	作者	年代	出处	被引量
1	Current state of biomarkerdevelopment for clinical application in epithelial ovarian cancer显示文摘	Moore RG MacLaughlan S Bast RC Jr	2010	Gynecol Oncol2010，116，2：	1
2	Laparoscopic live donor nephrectomy显示文摘	Ratner LE Ciseck LJ Moore RG		0，，：	1
3	A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass显示文摘	Moore RG McMeekin DS Brown AK	2009	Gynecol Oncol2009，112，1：	1
4	The use of multiple nov- el tumor biomarkers for the detection of ovarian carcinoma in pa- tients with a pelvic mass 显示文摘	Moore RG Brown AK Miller MC	2008	Gynecol Oncol2008，108，2：	1
5	The use of multiple no- vel tumor biomarkers for the detection of ovarian carcinoma in pa- tients with a pelvic mass显示文摘	Moore RG Brown AK Miller MC	2008	Gyneeol Oncol2008，108，：	1
6	The use of multiple no- vel tumor biomarkers for the detection of ovarian carcinoma in pa-tients with a pelvic mass显示文摘	Moore RG Brown AK Miller MC	2008	Gynecologic Oncology2008，108，2：	1
7	A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass 显示文摘	Moore RG McMeekin DS Brown AK	2009	Gynecol On- col2009，112，1：	1
8	The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass显示文摘	Moore RG Brown AK Miller MC	2008	Gynecol Oncol2008，108，2：	1
9	Incidence of metastasis to the ovaries from nongenital tract primary tumors 显示文摘	Moore RG Chung M Granai CO	2004	Gynecol Oncol2004，93，1：	1
10	Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus 显示文摘	Moore RG Brown AK Miller MC	2008	Gynecol Oncol2008，110，2：	1
11	Current state of biomarker development for clinical application in epithe- lial ovarian cancer显示文摘	Moore RG Maclaughlan S Jr RC Bast	2010	Gynecol Oncol2010，116，2：	1
12	Current state of blomar- kerdevelopmentforclinicalapplication in epithelialovairan cancer 显示文摘	Moore RG MacLnaghlan S Bast RC JR	2010	Gyneeol Oncol2010，116，2：	1
13	Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus显示文摘	Moore RG Brown AK Miller MC	2008	Gynecol Oncol2008，110，2：	1
14	Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus 显示文摘	Moore RG Brown AK Miller MC	2008	Gynecol Oncol2008，110，2：	1
15	Riluzole for amyotrophic lateral sclerosis ( ALS)/motor neuron disease (MND) 显示文摘	Miller RG Mitchell JD Moore DH	2000	Cochrane Database Syst Rev2000，2，：	1
16	A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of o- varian cancer in patients with a pelvic mass 显示文摘	Moore RG McMeekin DS Brown AK	2009	Gynecol Oncol2009，112，：	1
17	A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass显示文摘	Moore RG McMeekin DS Brown AK	2009	Gynecol Oncol2009，112，1：	1
18	Factor affecting response to thymectomy for myasthenia ggravis 显示文摘	Rubin JW Ellison RG Moore HV	1981	J Thoracic Cardiovasc Surg1981，82，：	1
19	The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass显示文摘	Moore RG Brown AK Miller MC	2008	Gynecol Oncol2008，108，2：	1
20	Current clinical use of biomarkers for epithelial ovarian cancer显示文摘	Moore RG Maclaughlan S Bast RC	2010	Curr Opin Oncol2010，22，5：	1

返回顶部每页显示：

共26页首页上一页第1页下一页末页 /26 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示